Zerone Cellvane’s dental department, specializing in PDRN, received an award for outstanding performance.

CEO Mr. Jong-il Yoon presented a work on PDRN at the Central Dental Congress organized by the Korean Dental Association and the Central Dental Association from November 3-5 in Daejeon.
Zerone Cellvane’s research was awarded for an excellence on November 10th, 2023.
Mr. Yoon presented on the dental implantation strategy by using DCP, in which DCP contains PDRN (Cellvane) to reduce inflammation from periodontitis and regenerate gums and bones.

PDRN has the qualification in reducing inflammation, creating new tissue, and stimulating new bone formation.
DCP is a new option for treating periodontitis which is difficult to treat.
Mr. Yoon said PDRN has potential for many other future dental treatments.
Zerone Cellvane plans to conduct further research to apply PDRN to dental implantation and treatment of periodontitis going forward.